181 related articles for article (PubMed ID: 32470298)
1.
Konstantinović J; Yahiaoui S; Alhayek A; Haupenthal J; Schönauer E; Andreas A; Kany AM; Müller R; Koehnke J; Berger FK; Bischoff M; Hartmann RW; Brandstetter H; Hirsch AKH
J Med Chem; 2020 Aug; 63(15):8359-8368. PubMed ID: 32470298
[TBL] [Abstract][Full Text] [Related]
2. Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH).
Voos K; Schönauer E; Alhayek A; Haupenthal J; Andreas A; Müller R; Hartmann RW; Brandstetter H; Hirsch AKH; Ducho C
ChemMedChem; 2021 Apr; 16(8):1257-1267. PubMed ID: 33506625
[TBL] [Abstract][Full Text] [Related]
3. Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa.
Kany AM; Sikandar A; Haupenthal J; Yahiaoui S; Maurer CK; Proschak E; Köhnke J; Hartmann RW
ACS Infect Dis; 2018 Jun; 4(6):988-997. PubMed ID: 29485268
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa elastase (LasB) as a therapeutic target.
Everett MJ; Davies DT
Drug Discov Today; 2021 Sep; 26(9):2108-2123. PubMed ID: 33676022
[TBL] [Abstract][Full Text] [Related]
5. Tackling Pseudomonas aeruginosa Virulence by a Hydroxamic Acid-Based LasB Inhibitor.
Kany AM; Sikandar A; Yahiaoui S; Haupenthal J; Walter I; Empting M; Köhnke J; Hartmann RW
ACS Chem Biol; 2018 Sep; 13(9):2449-2455. PubMed ID: 30088919
[TBL] [Abstract][Full Text] [Related]
6. Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
Alhayek A; Abdelsamie AS; Schönauer E; Camberlein V; Hutterer E; Posselt G; Serwanja J; Blöchl C; Huber CG; Haupenthal J; Brandstetter H; Wessler S; Hirsch AKH
J Med Chem; 2022 Oct; 65(19):12933-12955. PubMed ID: 36154055
[TBL] [Abstract][Full Text] [Related]
7. A drug-repositioning screening identifies pentetic acid as a potential therapeutic agent for suppressing the elastase-mediated virulence of Pseudomonas aeruginosa.
Gi M; Jeong J; Lee K; Lee KM; Toyofuku M; Yong DE; Yoon SS; Choi JY
Antimicrob Agents Chemother; 2014 Dec; 58(12):7205-14. PubMed ID: 25246397
[TBL] [Abstract][Full Text] [Related]
8. Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.
Cathcart GR; Quinn D; Greer B; Harriott P; Lynas JF; Gilmore BF; Walker B
Antimicrob Agents Chemother; 2011 Jun; 55(6):2670-8. PubMed ID: 21444693
[TBL] [Abstract][Full Text] [Related]
9. Structures of three polycystic kidney disease-like domains from Clostridium histolyticum collagenases ColG and ColH.
Bauer R; Janowska K; Taylor K; Jordan B; Gann S; Janowski T; Latimer EC; Matsushita O; Sakon J
Acta Crystallogr D Biol Crystallogr; 2015 Mar; 71(Pt 3):565-77. PubMed ID: 25760606
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of the insect metalloproteinase inhibitor against infections caused by Pseudomonas aeruginosa.
Eisenhardt M; Schlupp P; Höfer F; Schmidts T; Hoffmann D; Czermak P; Pöppel AK; Vilcinskas A; Runkel F
J Pharm Pharmacol; 2019 Mar; 71(3):316-328. PubMed ID: 30408181
[TBL] [Abstract][Full Text] [Related]
11. [Metalloproteases and their inhibitors: role in pathogenesis of selected examples].
Siemińska-Kuczer A; Vertyporokh L; Andrejko M; Wojda I; Stączek S; Zdybicka-Barabas A; Grygorczuk K; Cytryńska M
Postepy Biochem; 2017; 63(4):269-276. PubMed ID: 29374428
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
Li Y; Huang J; Li L; Liu L
Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
[TBL] [Abstract][Full Text] [Related]
13. Targeting Extracellular Bacterial Proteases for the Development of Novel Antivirulence Agents.
Kaya C; Hirsch AKH
Chimia (Aarau); 2022 May; 76(5):402-408. PubMed ID: 38069711
[TBL] [Abstract][Full Text] [Related]
14. Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth.
Schmidtchen A; Holst E; Tapper H; Björck L
Microb Pathog; 2003 Jan; 34(1):47-55. PubMed ID: 12620384
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of polyphenols from grape pomace extract on collagenase and elastase activity.
Wittenauer J; Mäckle S; Sußmann D; Schweiggert-Weisz U; Carle R
Fitoterapia; 2015 Mar; 101():179-87. PubMed ID: 25598188
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the binding specificity of two bacterial metalloproteases, LasB of Pseudomonas aeruginosa and ZapA of Proteus mirabilis, using N-alpha mercaptoamide template-based inhibitor analogues.
Carson L; Cathcart GR; Ceri H; Walker B; Gilmore BF
Biochem Biophys Res Commun; 2012 Jun; 422(2):316-20. PubMed ID: 22575503
[TBL] [Abstract][Full Text] [Related]
17. Relationship Among Antibiotic Resistance, Biofilm Formation and lasB Gene in Pseudomonas Aeruginosa Isolated from Burn Patients.
Roshani-Asl P; Rashidi N; Shokoohizadeh L; Zarei J
Clin Lab; 2018 Sep; 64(9):1477-1484. PubMed ID: 30274028
[TBL] [Abstract][Full Text] [Related]
18. Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases.
Matsumoto K; Shams NB; Hanninen LA; Kenyon KR
Invest Ophthalmol Vis Sci; 1993 May; 34(6):1945-53. PubMed ID: 8491548
[TBL] [Abstract][Full Text] [Related]
19. Disarming Pseudomonas aeruginosa virulence factor LasB by leveraging a Caenorhabditis elegans infection model.
Zhu J; Cai X; Harris TL; Gooyit M; Wood M; Lardy M; Janda KD
Chem Biol; 2015 Apr; 22(4):483-491. PubMed ID: 25892201
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs.
Supuran CT
Curr Med Chem; 2012; 19(6):831-44. PubMed ID: 22214451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
